Aspirin can have ‘huge effect’ in stopping colorectal cancer returning, study finds

Here is a 183-word summary of the news article: A new study has found that a daily low-dose of aspirin can significantly reduce the risk of colorectal cancer returning after surgery. Researchers in Sweden conducted a large trial involving post-surgery colorectal cancer patients and found that those who took a daily aspirin were half as likely to have their cancer return over the following three years compared to those who took a placebo. The protective effect of aspirin was specifically seen in patients with certain gene mutations. Experts believe aspirin's anti-inflammatory properties may help prevent the growth and spread of any remaining cancer cells after the initial tumor is removed. While more research is still needed, the findings suggest aspirin could have a "huge effect" in stopping colorectal cancer from recurring in some patients. The study adds to the growing body of evidence that the common painkiller may offer important benefits beyond its traditional uses.